Physician profile
Christopher White
NPI 1396326401
$1,560.38
in general payments reported to CMS, 2019-2025
16 companies · $50.47 in 2025
The $50.47 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.80 · 2022: $553 · 2023: $685 · 2024: $244 · 2025: $50.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $297.83 | 2022-2023 | Dalvance |
| Novo Nordisk INC | $241.20 | 2022-2024 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $223.19 | 2022-2023 | Eliquis |
| Inari Medical, INC. | $186.85 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $113.82 | 2023 | Tavneos |
| Horizon Therapeutics Plc | $90.85 | 2023 | Krystexxa |
| Penumbra, INC. | $76.17 | 2024 | Indigo System |
| Ucb, INC. | $65.19 | 2024 | |
| Pfizer INC. | $64.83 | 2022-2023 | |
| Lilly USA, LLC | $57.39 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $50.47 | 2025 | Airsupra |
| La Jolla Pharmaceutical Company | $28.80 | 2021 | |
| Radius Health, INC. | $18.97 | 2023 | Tymlos |
| Nestle Healthcare Nutrition INC. | $15.73 | 2022 | |
| Merck Sharp & Dohme LLC | $15.41 | 2023 | Dificid, Zerbaxa, Recarbrio |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $13.68 | 2023 | Myrisk |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.